90 related articles for article (PubMed ID: 12406819)
1. Montelukast prevents antigen-induced mucociliary dysfunction in sheep.
Sabater JR; Wanner A; Abraham WM
Am J Respir Crit Care Med; 2002 Dec; 166(11):1457-60. PubMed ID: 12406819
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan blocks porcine pancreatic elastase-induced mucociliary dysfunction in allergic sheep.
Scuri M; Sabater JR; Abraham WM
J Appl Physiol (1985); 2007 Jun; 102(6):2324-31. PubMed ID: 17395761
[TBL] [Abstract][Full Text] [Related]
3. Elastase contributes to antigen-induced mucociliary dysfunction in ovine airways.
O'Riordan TG; Otero R; Mao Y; Lauredo I; Abraham WM
Am J Respir Crit Care Med; 1997 May; 155(5):1522-8. PubMed ID: 9154852
[TBL] [Abstract][Full Text] [Related]
4. Budesonide affects allergic mucociliary dysfunction.
O'Riordan TG; Mao Y; Otero R; Lopez J; Sabater JR; Abraham WM
J Appl Physiol (1985); 1998 Sep; 85(3):1086-91. PubMed ID: 9729587
[TBL] [Abstract][Full Text] [Related]
5. The effect of montelukast on nasal mucociliary clearance.
Saieed WN; Alpachachi IA; Almashhadani WM
J Clin Pharmacol; 2006 May; 46(5):588-90. PubMed ID: 16638742
[No Abstract] [Full Text] [Related]
6. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
7. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
8. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
Leigh R; Vethanayagam D; Yoshida M; Watson RM; Rerecich T; Inman MD; O'Byrne PM
Am J Respir Crit Care Med; 2002 Nov; 166(9):1212-7. PubMed ID: 12403690
[TBL] [Abstract][Full Text] [Related]
9. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
10. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
[TBL] [Abstract][Full Text] [Related]
11. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
[TBL] [Abstract][Full Text] [Related]
12. Role of ciliary motility in acute allergic mucociliary dysfunction.
Maurer DR; Sielczak M; Oliver W; Abraham WM; Wanner A
J Appl Physiol Respir Environ Exerc Physiol; 1982 Apr; 52(4):1018-23. PubMed ID: 7085401
[TBL] [Abstract][Full Text] [Related]
13. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
14. The effects of a cysteinyl leukotriene antagonist (ONO-1078) on antigen-induced responses in allergic sheep.
Abraham WM; Ahmed A; Cortes A; Sielczak M; Hallmon J
Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):233-9. PubMed ID: 8469683
[TBL] [Abstract][Full Text] [Related]
15. Oxygen radicals contribute to antigen-induced airway hyperresponsiveness in conscious sheep.
Lansing MW; Ahmed A; Cortes A; Sielczak MW; Wanner A; Abraham WM
Am Rev Respir Dis; 1993 Feb; 147(2):321-6. PubMed ID: 8430955
[TBL] [Abstract][Full Text] [Related]
16. The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress.
Cikler E; Ersoy Y; Cetinel S; Ercan F
Acta Histochem; 2009; 111(2):112-8. PubMed ID: 18617226
[TBL] [Abstract][Full Text] [Related]
17. Mucociliary interaction in vitro: effects of physiological and inflammatory stimuli.
Seybold ZV; Mariassy AT; Stroh D; Kim CS; Gazeroglu H; Wanner A
J Appl Physiol (1985); 1990 Apr; 68(4):1421-6. PubMed ID: 1971819
[TBL] [Abstract][Full Text] [Related]
18. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.
Pearlman DS; van Adelsberg J; Philip G; Tilles SA; Busse W; Hendeles L; Loeys T; Dass SB; Reiss TF
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):98-104. PubMed ID: 16892789
[TBL] [Abstract][Full Text] [Related]
19. Montelukast, a selective cysteinyl leukotriene receptor 1 antagonist, reduces cerulein-induced pancreatic injury in rats.
Ozkan E; Akyüz C; Sehirli AO; Topaloğlu U; Ercan F; Sener G
Pancreas; 2010 Oct; 39(7):1041-6. PubMed ID: 20467345
[TBL] [Abstract][Full Text] [Related]
20. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
Langlois A; Ferland C; Tremblay GM; Laviolette M
J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
